Fresh Rounds

Angelis Oncology, Inc. funding

Angelis Oncology, Inc., a biotechnology company based in San Francisco, CA (founded 2026), filed a Form D with the SEC on July 23, 2026 and reported $400K raised.

Amount raised$400K
Offering sizeOpen-ended
Filed with the SECJuly 23, 2026
First saleJuly 10, 2026
IndustryBiotechnology
SecuritiesDebt
LocationSan Francisco, CA
Founded2026
Entity typeCorporation
Investors so far1
Minimum investment—
Revenue rangeDecline to Disclose

Other health care rounds in California